Assisted Reproductive Technology Industry Sizeworth $6.02 Billion by 2030

The report "Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030", is projected to reach USD 6.02 Billion by 2030 from USD 4.29 Billion in 2025 at a CAGR of 7.0% during the forecast period.

Browse 323 market data Tables and 51 Figures spread through 320 Pages and in-depth TOC on "Assisted Reproductive Technology Market by Technology (In Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/assisted-reproductive-technology-market-91934243.html

Global demand for assisted reproductive technology (ART) is driven by rising levels of fertility resulting from delayed conception, lifestyle shifts, and enhanced awareness of fertility treatments. Increased success rates from technology such as improved IVF success rates, preimplantation genetic testing (PGT), and cryopreservation are also driving the industry. The industry is also expanding due to supportive government policies, increased medical tourism, and emerging networks of fertility clinics. Growth is restrained by a variety of factors such as the high cost of therapy, moral and legal problems with ART, and potential health risks for the parents and children. The psychological and physical stress of ART treatments and limited access to fertility treatments in the developing world are concerns. Beyond these concerns, increased development, research, and accessibility are projected to propel the industry.

This report categorizes the assisted reproductive technology market based on technology, type, patient type, care settings and region.

Based on type, instruments segment accounted for the largest share assisted reproductive technology market

Equipment maintains the largest market share in the assisted reproductive technology (ART) market because they are at the forefront of fertility treatment and because reproductive technology is constantly changing.  Incubators, micromanipulators, imaging equipment, and cryopreservation equipment are needed for procedures like in-vitro fertilization (IVF), embryo culture, and freezing sperm or eggs. Also fueling the use of sophisticated instruments is demand for higher accuracy, automation, and efficiency in ART laboratories. This segment is also fueled by the increase in the number of fertility clinics, ART success rates, and research in reproductive medicine. Demand for superior-quality instruments is increasing steadily as ART procedures become more complicated and prevalent, solidifying their market leadership.

Based on technology, the IVF segment accounted for the assisted reproductive technology market

IVF accounts for the highest market share in the market for assisted reproductive technology because it has high success rates, universal usage, and ongoing technological progress. As the most effective method of treating fertility, in vitro fertilization can address different causes of infertility, including older mother age, male factor, and unexplained infertility. Because of the huge success provided by advances such as time-lapse imaging, freezing of the embryo, and preimplantation genetic screening, IVF is increasingly becoming the preferred treatment compared to other types of ART. Conception delay, rising infertility levels, and the rising awareness of fertility treatment are all contributing factors to the global demand for IVF. Increased growth of medical tourism, government encouragement for ART treatment, and the development of fertility clinics across the globe are other contributors to IVF's market leadership.

Based on care settings, the fertility clinic segment accounted of the assisted reproductive technology market

The fertility clinics segment is the largest assisted reproductive technology (ART) market share in care settings due to the increasing need for improved reproductive treatments, sophisticated medical infrastructure, and an increase in the number of cases of infertility worldwide. Fertility clinics offer the entire range of ART services, including in-vitro fertilization (IVF), intrauterine insemination (IUI), egg and sperm freezing, and preimplantation genetic testing (PGT), and therefore are patients' preferred destinations for fertility treatment. Fertility clinics are armed with the best technology, highly skilled professionals, and specialty labs, which give improved success rates for ART treatments.

Moreover, increasing awareness about fertility treatments, government subsidies, and the mushrooming of private fertility centers also contributed to the growth of this segment. The increasing trend of medical tourism for low-cost ART treatments in India, Thailand, and Spain also contributes to the dominance of the fertility clinics in the ART market.

The Asia Pacific market is expected to grow at a higher CAGR during the forecast period

Asia-Pacific is forecasted to grow at the highest rate in the assisted reproductive technology (ART) market in the next five years with the rising rate of infertility, increased awareness of fertility treatment, and an enhanced healthcare infrastructure. Lifestyle changes, postponed childbearing, and stress-related infertility are significant drivers of demand for ART procedures in the region. Government policies for infertility treatment, increased number of fertility clinics, and innovation in reproductive technology are propelling the market growth. Cost-effectiveness of ART procedures compared to Western nations and increasing medical tourism also fuel the growth of the market in the region. Increased acceptability of fertility preservation technologies such as egg freezing and surrogacy, and an increased number of middle-class individuals with improved disposable income, is expected to fuel long-term market growth in Asia-Pacific.

Key players in the assisted reproductive technology market

Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), Thermo Fisher Scientific Inc. (US), LENUS Pharma GesmbH (Austria), Zita West (UK), Kitazato Corporation (Japan), Exeltis USA, Inc. (US), Vitabiotics Ltd (UK), FertiPro NV (Belgium), and AdvaCare Pharma (US), among others.

Don’t miss out on business opportunities in Assisted Reproductive Technology Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/